Browsing: Weight Loss

The recent pullback in Novo Nordisk stock after its guidance update has put a harsh spotlight on obesity and metabolic disorder therapeutics. The market reaction underscored how sensitive investors are to clinical data, pipeline clarity, and competitive pressure from Eli Lilly’s obesity drugs. For you, this creates a chance to reassess exposure to companies tied…

Coverage for GLP-1 denied after weight loss Aug. 5, 202603:31 Now Playing Coverage for GLP-1 denied after weight loss 03:31 UP NEXT Deadly home explosion in Illinois 01:17 Salmonella outbreak expands to 27 states 02:03 Dogs maul boy during Bahamas vacation 01:53 New details on suspect arrested at Trump golf club 01:48 Progressive Democrat scores…